Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

The DABBEC Phenotyping System: towards a mechanistic understanding of CP/CPPS

Abstract

There is an urgent need to elucidate the mechanistic basis of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), as the current methods of symptom-based diagnosis and treatment have failed. Here, we propose a phenotyping system that bridges the gap between the symptom-based diagnosis and treatment of the present and the mechanistic approach of the future. Our phenotyping system uses the Chronic Prostatitis Collaborative Research Network (CPCRN)-recommended algorithm in combination with the NIH Chronic Prostatitis Symptom Index (NIH-CPSI) as a basis for diagnosis, while incorporating novel domains for quantitative assessment and stratification of CP/CPPS patients. We believe this novel system will serve to help advance our understanding of the roles of the patient's genome and proteome in the etiology of CP/CPPS. We predict that, as we begin to understand the mechanistic basis of CP/CPPS pathology and progression, we will develop specific treatments that will aim to cure the disease, rather than merely quell the symptoms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The open-hidden study design.
Figure 2: The delayed-start study design.

Similar content being viewed by others

References

  1. Krieger, J. N., Nyberg, L. Jr & Nickel, J. C. NIH consensus definition and classification of prostatitis. JAMA 282, 236–237 (1999).

    Article  CAS  PubMed  Google Scholar 

  2. Collins, M. M., Stafford, R. S., O'Leary, M. P. & Barry, M. J. How common is prostatitis? A national survey of physician visits. J. Urol. 159, 1224–1228 (1998).

    Article  CAS  PubMed  Google Scholar 

  3. Calhoun, E. A. et al. The economic impact of chronic prostatitis. Arch. Intern. Med. 164, 1231–1236 (2004).

    Article  PubMed  Google Scholar 

  4. McNaughton Collins, M. et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J. Gen. Intern. Med. 16, 656–662 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Propert, K. J. et al. Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology 59, 870–876 (2002).

    Article  PubMed  Google Scholar 

  6. Pontari, M. A. & Ruggieri, M. R. Mechanisms in prostatitis/chronic pelvic pain syndrome. J. Urol. 172, 839–845 (2004).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Rodriguez, M. A. et al. Evidence for overlap between urological and nonurological unexplained clinical conditions. J. Urol. 182, 2123–2131 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Litwin, M. S. et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J. Urol. 162, 369–375 (1999).

    Article  CAS  PubMed  Google Scholar 

  9. Alexander, R. B. et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann. Intern. Med. 141, 581–589 (2004).

    Article  CAS  PubMed  Google Scholar 

  10. Nickel, J. C. et al. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N. Engl. J. Med. 359, 2663–2673 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shoskes, D. A., Nickel, J. C., Dolinga, R. & Prots, D. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology 73, 538–542 (2009).

    Article  PubMed  Google Scholar 

  12. Nickel, J. C. & Shoskes, D. Phenotypic approach to the management of chronic prostatitis/chronic pelvic pain syndrome. Curr. Urol. Rep. 10, 307–312 (2009).

    Article  PubMed  Google Scholar 

  13. Shoskes, D. A., Nickel, J. C. & Kattan, M. W. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 75, 1249–1253 (2010).

    Article  PubMed  Google Scholar 

  14. Nickel, J. in Campbell-Walsh Urology 9th edn (eds. Wein, A. J. et al.) 312–314 (Saunders, Philadelphia, 2007).

    Google Scholar 

  15. Nickel, J. C. Clinical evaluation of the man with chronic prostatitis/chronic pelvic pain syndrome. Urology 60, 20–22; discussion 22–23 (2002).

    Article  PubMed  Google Scholar 

  16. Latremoliere, A. & Woolf, C. J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain 10, 895–926 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  17. Scholz, J. & Woolf, C. J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 10, 1361–1368 (2007).

    Article  CAS  PubMed  Google Scholar 

  18. Woolf, C. J. & Ma, Q. Nociceptors—noxious stimulus detectors. Neuron 55, 353–364 (2007).

    Article  CAS  PubMed  Google Scholar 

  19. Costigan, M., Scholz, J. & Woolf, C. J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu. Rev. Neurosci. 32, 1–32 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Patapoutian, A., Tate, S. & Woolf, C. J. Transient receptor potential channels: targeting pain at the source. Nat. Rev. Drug Discov. 8, 55–68 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Nickel, J. C. et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 103, 910–918 (2009).

    Article  CAS  PubMed  Google Scholar 

  22. Anderson, R. U., Orenberg, E. K., Morey, A., Chavez, N. & Chan, C. A. Stress induced hypothalamus–pituitary–adrenal axis responses and disturbances in psychological profiles in men with chronic prostatitis/chronic pelvic pain syndrome. J. Urol. 182, 2319–2324 (2009).

    Article  CAS  PubMed  Google Scholar 

  23. Lutgendorf, S. K. et al. Diurnal cortisol variations and symptoms in patients with interstitial cystitis. J. Urol. 167, 1338–1343 (2002).

    Article  PubMed  Google Scholar 

  24. McEwen, B. S. & Kalia, M. The role of corticosteroids and stress in chronic pain conditions. Metabolism 59 (Suppl. 1), S9–S15 (2010).

    Article  CAS  PubMed  Google Scholar 

  25. Ganzel, B. L., Morris, P. A. & Wethington, E. Allostasis and the human brain: integrating models of stress from the social and life sciences. Psychol. Rev. 117, 134–174 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  26. Dimitrakov, J. et al. Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 71, 261–266 (2008).

    Article  PubMed  Google Scholar 

  27. Nimkarn, S. & New, M. I. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a paradigm for prenatal diagnosis and treatment. Ann. NY Acad. Sci. 1192, 5–11 (2010).

    Article  CAS  PubMed  Google Scholar 

  28. Cohen, H., Neumann, L., Glazer, Y., Ebstein, R. P. & Buskila, D. The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158)met and fibromyalgia. Clin. Exp. Rheumatol. 27 (5 Suppl. 56), S51–S56 (2009).

    CAS  PubMed  Google Scholar 

  29. Tegeder, I. et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat. Med. 12, 1269–1277 (2006).

    Article  CAS  PubMed  Google Scholar 

  30. Ross, S. E. et al. Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice. Neuron 65, 886–898 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Patte-Mensah, C. et al. Neurogenic pain and steroid synthesis in the spinal cord. J. Mol. Neurosci. 28, 17–31 (2006).

    Article  CAS  PubMed  Google Scholar 

  32. Schaeffer, V., Meyer, L., Patte-Mensah, C. & Mensah-Nyagan, A. G. Progress in dorsal root ganglion neurosteroidogenic activity: basic evidence and pathophysiological correlation. Prog. Neurobiol. 92, 33–41 (2010).

    Article  CAS  PubMed  Google Scholar 

  33. Savoye-Collet, C., Koning, E. & Dacher, J. N. Radiologic evaluation of pelvic floor disorders. Gastroenterol. Clin. North Am. 37, 553–567 (2008).

    Article  PubMed  Google Scholar 

  34. Siddall, P. J. et al. Magnetic resonance spectroscopy detects biochemical changes in the brain associated with chronic low back pain: a preliminary report. Anesth. Analg. 102, 1164–1168 (2006).

    Article  PubMed  Google Scholar 

  35. Kuchinad, A. et al. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J. Neurosci. 27, 4004–4007 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Schmidt-Wilcke, T. et al. Striatal grey matter increase in patients suffering from fibromyalgia—a voxel-based morphometry study. Pain 132 (Suppl. 1), S109–S116 (2007).

    Article  PubMed  Google Scholar 

  37. Dunckley, P. et al. Cortical processing of visceral and somatic stimulation: differentiating pain intensity from unpleasantness. Neuroscience 133, 533–542 (2005).

    Article  CAS  PubMed  Google Scholar 

  38. Schaeffer, A. J., Parks, E. L. & Apkarian, A. V. Brain Activity for spontaneous fluctuations of pain in urologic pelvic pain syndrome [abstract]. J. Urol. 181 (Suppl. 4), 121 (2009).

    Article  Google Scholar 

  39. Bjerklund Johansen, T. E. & Weidner, W. Understanding chronic pelvic pain syndrome. Curr. Opin. Urol. 12, 63–67 (2002).

    Article  PubMed  Google Scholar 

  40. Katsnelson, A. Researchers probe the real effect of placebos. Nat. Med. 11, 105 (2005).

    Article  CAS  PubMed  Google Scholar 

  41. Finniss, D. G., Kaptchuk, T. J., Miller, F. & Benedetti, F. Biological, clinical, and ethical advances of placebo effects. Lancet 375, 686–695 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  42. Benedetti, F., Amanzio, M. & Maggi, G. Potentiation of placebo analgesia by proglumide. Lancet 346, 1231 (1995).

    Article  CAS  PubMed  Google Scholar 

  43. D'Agostino, R. B. Sr. The delayed-start study design. N. Engl. J. Med. 361, 1304–1306 (2009).

    Article  CAS  PubMed  Google Scholar 

  44. Colloca, L., Lopiano, L., Lanotte, M. & Benedetti, F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 3, 679–684 (2004).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed equally to researching data for the article, discussing its content, writing and review/editing of the manuscript before publication.

Corresponding author

Correspondence to Jordan D. Dimitrakoff.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allsop, S., Erstad, D., Brook, K. et al. The DABBEC Phenotyping System: towards a mechanistic understanding of CP/CPPS. Nat Rev Urol 8, 107–113 (2011). https://doi.org/10.1038/nrurol.2010.227

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2010.227

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing